Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
Presenting Author: Thomas O’Hare
Publications
Preclinical discovery and characterization of EO-1022, a site-specific glycan-conjugated anti-HER3 vcMMAE ADC for treating solid tumors
Posters & Oral Presentations